Future Gen Biopharm
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $62M
Investors
- 5
About Future Gen Biopharm
Founded in 2014 and based in Beijing, China, Future Gen Biopharm is a medical company that focuses on the development of antibody drugs and reagent antibodies that can be used in scientific research and clinical applications based on biotechnology. Zhaoyu Jin, the chairman and CEO of the Company, holds a PhD degree in Pharmacology from the University of Pennsylvania in the United States, used to work for Genentech and other biopharmaceutical companies. The company's manufacturing base was completed in Beijing in 2020. It received clinical approval for its M108 program in 2021. Future Gen Biopharm's main product category is innovative biopharmaceuticals for tumor immunotherapy. It designs and develop innovative monoclonal antibody, bis-antibody, poly-antibody and ADC drugs based on its STEP platform, biofunctional analysis platform, and CMC production platform. Products within include FG-B901, FG-B310, FG-M234. The company's products have been used in oncology and immune diseases.
Who invested in Future Gen Biopharm
5 investors across 2 rounds
See all investors in Future Gen Biopharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Future Gen Biopharm
Who invested in Future Gen Biopharm?
Future Gen Biopharm has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Future Gen Biopharm raised?
Future Gen Biopharm has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Future Gen Biopharm last raise money?
Future Gen Biopharm's most recent round on record is a Series B, in Mar 2021.
What does Future Gen Biopharm do?
Founded in 2014 and based in Beijing, China, Future Gen Biopharm is a medical company that focuses on the development of antibody drugs and reagent antibodies that can be used in scientific research and clinical applications based on biotechnology.
Where is Future Gen Biopharm headquartered?
Future Gen Biopharm is headquartered in Beijing, China.
Which VCs invest in companies like Future Gen Biopharm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Future Gen Biopharm's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Future Gen Biopharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.